Simplex Trading’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.75K | Sell |
455
-467
| -51% | -$6.26K | ﹤0.01% | 7791 |
|
|
2025
Q4 | $14.5K | Buy |
922
+75
| +9% | +$953 | ﹤0.01% | 6742 |
|
|
2025
Q3 | $10K | Buy |
847
+497
| +142% | +$3.97K | ﹤0.01% | 7877 |
|
|
2025
Q2 | $2K | Buy |
+350
| New | +$2.1K | ﹤0.01% | 8118 |
|
|
2025
Q1 | – | Sell |
-56
| Closed | -$346 | – | 8767 |
|
|
2024
Q4 | $0 | Sell |
56
-165
| -75% | -$1.58K | ﹤0.01% | 8777 |
|
|
2024
Q3 | $2K | Sell |
221
-1,048
| -83% | -$13.7K | ﹤0.01% | 7985 |
|
|
2024
Q2 | $16K | Buy |
1,269
+380
| +43% | +$5.13K | ﹤0.01% | 7064 |
|
|
2024
Q1 | $15K | Buy |
889
+150
| +20% | +$1.99K | ﹤0.01% | 7319 |
|
|
2023
Q4 | $6K | Buy |
+739
| New | +$6.89K | ﹤0.01% | 7737 |
|
|
2023
Q3 | – | Sell |
-188
| Closed | -$4K | – | 8937 |
|
|
2023
Q2 | $4K | Sell |
188
-62
| -25% | -$1.83K | ﹤0.01% | 8022 |
|
|
2023
Q1 | $10K | Hold |
250
| – | – | ﹤0.01% | 7535 |
|
|
2022
Q4 | $11K | Buy |
+250
| New | +$11.4K | ﹤0.01% | 7443 |
|
|
2022
Q1 | – | Sell |
-2,428
| Closed | -$158K | – | 10623 |
|
|
2021
Q4 | $181K | Buy |
+2,428
| New | +$191K | ﹤0.01% | 5331 |
|
|
2020
Q3 | – | Sell |
-70
| Closed | -$3.39K | – | 7950 |
|
|
2020
Q2 | $3K | Sell |
70
-371
| -84% | -$19.2K | ﹤0.01% | 7138 |
|
|
2020
Q1 | $22K | Buy |
+441
| New | +$23.5K | ﹤0.01% | 5865 |
|
|
2019
Q4 | – | Sell |
-893
| Closed | -$55.4K | – | 7435 |
|
|
2019
Q3 | $53K | Buy |
+893
| New | +$66.3K | ﹤0.01% | 4967 |
|
|
2019
Q1 | – | Sell |
-316
| Closed | -$28.3K | – | 7286 |
|
|
2018
Q4 | $22K | Buy |
+316
| New | +$24.2K | ﹤0.01% | 5248 |
|
|
2018
Q3 | – | Sell |
-4,390
| Closed | -$440K | – | 7550 |
|
|
2018
Q2 | $508K | Buy |
+4,390
| New | +$438K | ﹤0.01% | 2437 |
|
|
2018
Q1 | – | Sell |
-5,644
| Closed | -$434K | – | 6313 |
|
|
2017
Q4 | $331K | Buy |
+5,644
| New | +$283K | 0.01% | 938 |
|
|
2017
Q3 | – | Sell |
-4,953
| Closed | -$199K | – | 6047 |
|
|
2017
Q2 | $178K | Buy |
+4,953
| New | +$158K | 0.01% | 1267 |
|
|
2016
Q2 | – | Sell |
-172
| Closed | -$4.5K | – | 5934 |
|
|
2016
Q1 | $5K | Sell |
172
-9,300
| -98% | -$259K | ﹤0.01% | 4067 |
|
|
2015
Q4 | $312K | Buy |
9,472
+8,922
| +1,622% | +$291K | 0.02% | 624 |
|
|
2015
Q3 | $19K | Sell |
550
-28
| -5% | -$1.2K | ﹤0.01% | 2840 |
|
|
2015
Q2 | $26K | Sell |
578
-365
| -39% | -$14.2K | ﹤0.01% | 2227 |
|
|
2015
Q1 | $28K | Sell |
943
-736
| -44% | -$28.6K | ﹤0.01% | 2031 |
|
|
2014
Q4 | $85K | Buy |
+1,679
| New | +$75.2K | 0.01% | 1025 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Simplex Trading's ENTA Position: Q1 2026 in Review
Simplex Trading reduced its Enanta Pharmaceuticals (ENTA) stake by 51% in Q1 2026, selling an estimated $6.26K and leaving 455 shares worth $5.75K. The position accounts for ﹤0.01% of the portfolio, ranked #7791.
Simplex Trading first reported a position in ENTA in Q4 2014 and has held it in 26 quarters since. The position peaked at $508K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Simplex Trading held 455 shares of Enanta Pharmaceuticals worth $5.75K as of Q1 2026.
- Simplex Trading sold 467 Enanta Pharmaceuticals shares in Q1 2026, an estimated $6.26K.
- Enanta Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7791 holding.
- Simplex Trading first reported a position in Enanta Pharmaceuticals in Q4 2014 and has held it in 26 quarters since.
- Simplex Trading's Enanta Pharmaceuticals position peaked at $508K in Q2 2018.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.